Fintel reports that on February 7, 2025, HC Wainwright & Co. initiated coverage of Vertical Aerospace (NYSE:EVTL) with a Buy ...

Gold Royalty (NYSE:GROY – Free Report) had its price objective lifted by HC Wainwright from $5.50 to $5.75 in a report issued on Wednesday morning,Benzinga reports. The firm currently has a buy rating ...

HC Wainwright restated their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report report published on Wednesday,Benzinga reports. The firm currently has a $12.00 price ...

H.C. Wainwright initiated coverage of Vertical Aerospace (EVTL) with a Buy rating and $12 price target The company specializes in designing ...

H.C. Wainwright lowered the firm’s price target on Neurocrine (NBIX) to $185 from $190 and keeps a Buy rating on the shares. FY25 Ingrezza ...

H.C. Wainwright analyst Mike Colonnese reiterated the Buy rating on CleanSpark, Inc. (NASDAQ:CLSK), with a price forecast of ...

H.C. Wainwright analyst Mitchell S. Kapoor revised the price target on Alumis Inc (NASDAQ:ALMS) to $19.00, down from the previous target of $26.00, while retaining a Buy rating for the company's ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

Investors in the United States and abroad are girding themselves for a turbulent week amid a looming tariff war.

In this article, we will discuss the 12 Best Healthcare Stocks to Buy According to Analysts. McKinsey reported that, since ...